Lidocaïne / Adrenaline Aguettant

Lidocaine hydrochloride, the active ingredient in Lidocaïne / Adrenaline Aguettant, is a local anesthetic presented as a sterile solution for injection for epidural, infiltration and perineural use. It provides rapid onset numbing of targeted tissues and is combined with epinephrine to extend its effect in minor surgical procedures.

GNH USA supplies Lidocaïne / Adrenaline Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaïne / Adrenaline Aguettant is a combined local anesthetic and vasoconstrictor used in procedures that require temporary loss of sensation.

- Minor surgical procedures: provides rapid, localized anesthesia with prolonged duration due to epinephrine‑induced vasoconstriction. - Epidural analgesia: delivers continuous pain relief during labor or postoperative recovery. - Peripheral nerve blocks: facilitates targeted nerve blockade for orthopedic or dental interventions.

Lidocaïne / Adrenaline Aguettant may cause a range of adverse reactions.

Common Side Effects: - Injection site pain or burning sensation. - Transient tachycardia or mild hypertension. - Dizziness or light‑headedness. - Nausea or mild vomiting. - Localised swelling or erythema. - Tingling or numbness beyond the intended area.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with rash, bronchospasm, or angioedema. - Cardiac arrhythmias or myocardial ischemia due to systemic epinephrine. - Central nervous system toxicity such as seizures or profound confusion. - Prolonged hypotension or cardiovascular collapse. - Systemic lidocaine toxicity presenting as metallic taste, tinnitus, or loss of consciousness. - Rare cases of methemoglobinemia.

When using Lidocaïne / Adrenaline Aguettant, consider the following safety measures.

- Allergy assessment: verify no known hypersensitivity to lidocaine or epinephrine. - Cardiovascular status: use cautiously in patients with uncontrolled hypertension, arrhythmias, or ischemic heart disease. - Pregnancy: evaluate risk‑benefit; limited data, use only if clearly needed. - Drug interactions: review concomitant MAO inhibitors, beta‑blockers, and other local anesthetics. - Dosage limits: adhere to maximum recommended dose per procedure to avoid systemic toxicity. - Store at room temperature: keep in original container, protect from light and moisture.

Lidocaïne / Adrenaline Aguettant can interact with several drug classes.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis when epinephrine is absorbed. - Beta‑blockers: can potentiate bradycardia or mask tachycardia signs of toxicity. - Class I antiarrhythmics (e.g., quinidine): increase risk of cardiac toxicity.

Moderate Interactions (Monitor Closely): - Other local anesthetics: cumulative systemic toxicity risk. - Tricyclic antidepressants: may lower seizure threshold. - Diuretics: may enhance systemic absorption of epinephrine, affecting blood pressure.